top of page

  HOME HEALTH CARE

           invenire prorsus et agere in tempore

FOR INVESTORS

the company's value today is 2 million US dollars (based on the entry of the first investor) Until November, the price of 1% of the company's shares is 10,000 US dollars. With the beginning of public activity and the sale of the first batch of devices, the price will be significantly increased. We are not seeking to attract investors; we are looking for a strategic partner capable of providing further funding before the IPO.

Welcome aboard. Let's make a profit together.

NUMBER OF SHARES SOLD :  

                                    42 000

We are looking for partners, investors and are open to cooperation
bottom of page